Category: Workers Comp

571 posts found

Marijuana Developments

White House Issues Executive Order to Reschedule Marijuana

Rescheduling marijuana to Schedule III will allow for greater clinical research, possible FDA-approved drugs, and more.

Legislation & Policy

States Consider Expanding Presumptions

So far in 2026, eight states and counting are seeking to expand existing presumptions or create new presumptions.

Innovation

Could AI-Designed Drugs Impact Regulatory Frameworks?

While AI can be effective in some elements of drug design, AI models currently struggle to explain their decision making, a key component of drug review.

Healthe Developments

Preliminary Findings from the 2026 Workers’ Comp Industry Insights Survey Report

Risk & Insurance® magazine published high-level findings from the eighth annual survey, in collaboration with Healthesystems.

Medmonitor

CMS Drug Pricing Negotiation to Lower Costs of 15 Drugs

The 2025 negotiations covered drugs for obesity, cancer, diabetes, COPD, asthma, and more.

This Month's Must Read

The Injured Worker: An Essential, Sometimes Overlooked Partner in Improving Pharmacy Network Utilization

Engaging directly with injured workers is one important way to improve pharmacy network utilization in workers’ comp.

Marijuana Updates

JAMA Publishes New Review for Therapeutic Use of Cannabis

The review examines the efficacy of cannabis therapy for various indications, including chronic pain and psychiatric conditions.

Industry Trends

Minnesota Reports on Prescription Drug Price Transparency

Drug classes with the most new, high-priced drugs were anti-cancer drugs, ADHD/anti-obesity drugs, and anti-inflammatory pain medications.

Legislation & Policy

New York Could Remove References to CDC Guidelines

After regional public health collaboratives formed in September, New York could be the first state to formally shift policies away from deferring to federal guidelines.

Medmonitor

White House Announces Deal to Expand Access to GLP-1 Medications

Qualifying CMS patients could pay as little as $50 a month for Ozempic or Wegovy.

This Month's Must Read

Common Exceptions: The Rising Incidence of Complex Claims in Workers’ Compensation

Understanding the factors that drive longer claim duration and higher costs.

Legislation & Policy

California to Expedite Research Around Schedule I & II Drugs

Assembly Bill 1103 was enacted, allowing for the Research Advisory Panel to expedite the review and approval of research applications.

Workforce Trends

NCCI Reports on Remote Work and Workers’ Comp Frequency

According to the NCCI, remote work makes up 20–30% of the U.S. workforce, up from 4–7% pre-pandemic.

Clinical Insights

JAMA Study Notes Possible Cardiovascular Benefits for GLP-1 Antagonists

Patients taking semaglutide or tirzepatide had a more than 40% lower risk of hospitalization for heart failure compared with patients taking drugs to lower blood sugar.

Healthe Developments

Healthe Leaders Share Insights

CEO Daryl Corr and SVP Todd Piscoitti were featured in WorkCompWire’s Leaders Speak series, while VP of Clinical Services, Silvia Sacalis’ recaps her National Comp presentation.

Prev 1 2 3 4 5 … 35 36 37 38 39 Next